About Brook Byers
Brook Byers is a director at Octave Bioscience.
Brook Byers reports to the SEC as a director or major shareholder of 5 public companies, including CareDx (CDNA), Pacific Biosciences of California (PACB) and Foundation Medicine (FMI).
Brook Byers first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Brook Byers in the role, so the role may have started earlier or lasted longer.
CI
CareDx, Inc.
Director and 10% owner
2014 – 2016 · Public company (CDNA)
PI
Pacific Biosciences of California, Inc.
Director
2010 – 2016 · Public company (PACB)
FI
Foundation Medicine, Inc.
Director
2013 – 2015 · Public company (FMI)
VI
Veracyte, Inc.
Director and 10% owner
2013 – 2014 · Public company (VCYT)
GI
Genomic Health Inc.
Director
2006 – 2011 · Public company (GHDX)
Key Colleagues at Startups
The people Brook Byers works with at each company, as listed on that company's latest Form D.
Octave Bioscience Inc · Form D, Mar 24, 2025
AI
A. Grant Heidrich III
Director
GS
George Scangos
Director
WH
William Hagstrom
Director
MK
Marcel Konrad
Executive officer
Thomas Hawes
Director
DB
Doug Biehn
Chief Executive Officer and director
LC
Lucy Coassin
Director
MP
Michael Pellini
Director